351 companies are selling unapproved stem cell treatments

Conceptual cellsHOUSTON: The study found that 570 clinics in almost every state in the U.S. are marketing unproven stem cell interventions for a range of ailments, including orthopaedic injuries and neurological disorders. The two authors of the study, Paul Knoepfler and Leigh Turner, said this is so risky…

Full story covered in the Dementia Business Weekly.